Pellegatta, G.; Mangiavillano, B.; Semeraro, R.; Auriemma, F.; Carlani, E.; Fugazza, A.; Vespa, E.; Repici, A.
The Effect of Hyaluronic Acid and Chondroitin Sulphate-Based Medical Device Combined with Acid Suppression in the Treatment of Atypical Symptoms in Gastroesophageal Reflux Disease. J. Clin. Med. 2022, 11, 1890.
https://doi.org/10.3390/jcm11071890
AMA Style
Pellegatta G, Mangiavillano B, Semeraro R, Auriemma F, Carlani E, Fugazza A, Vespa E, Repici A.
The Effect of Hyaluronic Acid and Chondroitin Sulphate-Based Medical Device Combined with Acid Suppression in the Treatment of Atypical Symptoms in Gastroesophageal Reflux Disease. Journal of Clinical Medicine. 2022; 11(7):1890.
https://doi.org/10.3390/jcm11071890
Chicago/Turabian Style
Pellegatta, Gaia, Benedetto Mangiavillano, Rossella Semeraro, Francesco Auriemma, Elisa Carlani, Alessandro Fugazza, Edoardo Vespa, and Alessandro Repici.
2022. "The Effect of Hyaluronic Acid and Chondroitin Sulphate-Based Medical Device Combined with Acid Suppression in the Treatment of Atypical Symptoms in Gastroesophageal Reflux Disease" Journal of Clinical Medicine 11, no. 7: 1890.
https://doi.org/10.3390/jcm11071890
APA Style
Pellegatta, G., Mangiavillano, B., Semeraro, R., Auriemma, F., Carlani, E., Fugazza, A., Vespa, E., & Repici, A.
(2022). The Effect of Hyaluronic Acid and Chondroitin Sulphate-Based Medical Device Combined with Acid Suppression in the Treatment of Atypical Symptoms in Gastroesophageal Reflux Disease. Journal of Clinical Medicine, 11(7), 1890.
https://doi.org/10.3390/jcm11071890